Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (27937)	2/11/1999 10:00:00 PM
From: Manzanillo	Read Replies (1) \| Respond to of 31646

<<The company is promoting a drug that doesn't work, but the stock gets repeatedly squeezed due to the small float and very large short position.>> You have been saying that for over two years now. Didn't you use to have the screen name Harddata over on Motley Fool on AOL? I made a bundle with ZONA and am sure will do the same with TAVA. <<The latest runup was due to a false report issued by one of their underwriters. >> Are you trying to tell me that no one cares about your false reports but that false reports from other people have a real impact on the stock? If you can't do anything to a stock like ZONA with almost no float, your impact on TAVA would be similar to a mosquito biting an elephant. <<When the FDA rejects Vasomax the stock will drop to the single digits in minutes.>> Why didn't you wait then? Everyone knows the approximate time for the FDA final approval. Why short the stock in August? Don't you know what good timing means?